The fast transmission of infectious diseases around the world – a new concern to the public health  by Fujita, Dennis Minoru et al.
LT
a
h
D
T
(
i
s
t
e
s
p
s
s
a
t
t
b
c
m
d
a
l
t
e
t
a
w
a
ibraz j infect dis 2 0 1 6;2  0(5):513–515
www.elsev ier .com/ locate /b j id
The Brazilian Journal of
INFECTIOUS  DISEASES
etter to the Editor
he fast  transmission  of  infectious  diseases
round the  world  – a new  concern  to the  public
ealth
ear Editor,
he high number of people traveling around the world
1,184,000,000 trips in 2015) with ∼45% participation of emerg-
ng countries tourists, allied to their hostage of international
portive mass gatherings events (Fig. 1A and B), increase
he potential risk for infectious diseases transmission due to
merging countries recently challenged public health systems
till devoted to endemic diseases issues associated to older
olicy.1
International travelers from emerging countries, like Brazil,
eems to be different to most country people with distinct
ocial status and better health, shown by travel expenditure
nd travel insurance claims (Fig. 1C and D), corroborating to
he “healthy immigrant effect”.2
Imported infectious diseases represent a new problem for
hese international travelers, where we see outbreaks caused
y people visiting endemic or risky areas, including developed
ountries, and bring back previously controlled diseases like
easles and mumps in Brazil – 2014/2015.3
The infectious disease control imposed by some nations,
ue to increased travel, leads to rethinking public health as
 larger phenomenon. The current models of border surveil-
ance, either by entry visa, limited length of stay or mandatory
ravel insurance (Schengen Convention), do not seem as
ffective in preventing the migration of infectious diseases
ransported both by foreign visitors or returning travelers. As
n example, the recent Zika Virus epidemic in Brazil and fast
orldwide spread, possibly a large-scale pandemic, promoted
 global mobilization to control and study a new emerg-
ng disease,4 denoting the discussion of an important topic:infectious diseases are no longer limited to governmental bor-
ders or poor nations, they are a worldwide problem, especially
the neglected ones.
Emerging countries with recently established public health
systems are exquisitely exposed to new diseases outbreaks
due to the recent increasing international travel, requir-
ing more  preventive measures both for border surveillance
or control of their returning travelers, in a challenge for
their endemic diseases dedicated systems. The full imple-
mentation of WHO’s 2005 International Health Regulations,
which includes the International Certiﬁcate of Vaccina-
tion and Prophylaxis, is mainly oriented to developed
countries. Revision of these Regulations is required both to
include this newcomer emerging systems but also vaccine-
preventable diseases transferred from developed countries.5
Travel Insurance should be an important tool due to the
possibility of travelers to receive medical treatment that
would prevent bringing back infectious diseases to their home
countries.
We believe that it is mandatory to create a unique global
network in order to improve the notiﬁcation of easily trans-
mitted diseases and also unknown diseases, where everyone
should adopt rigid protocols to provide information regarding
new or current outbreaks. In addition, all data must be avail-
able for all nations, which could ultimately lead health policy
makers around the world to get full access regarding all uni-
ﬁed outbreak alerts. Probably, we could tackle H1N1, Ebola, and
Zika virus epidemics more  effectively and maybe researchers
could gather more  information to eventually help Health
Authorities to prevent future epidemics, and speed up treat-
ment of sick people.
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Fig. 1 – A – International tourism in the world (triangles)/advanced (dots) or emerging (squares) countries, expressed as
millions of arrivals (closed symbols). B – Percentage of world arrivals from each origin. Dotted lines represent the 95%
conﬁdence interval of regression lines. p-Values are the comparison of slopes between regressions. C – Expenditure of
Brazilian tourists abroad. D – Travel insurance indexes of Brazilian tourists abroad. Straight lines represent regression lines
and correspondent interrupted lines represent the 95% conﬁdence intervals.
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